- Report
- August 2024
- 250 Pages
Global
From €2177EUR$2,290USD£1,829GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- May 2024
- 271 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 148 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 371 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- February 2025
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- May 2024
- 389 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- January 2025
- 190 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- August 2023
- 250 Pages
Global
From €1892EUR$1,990USD£1,589GBP

Vitiligo is a skin condition characterized by the loss of skin color in patches. It affects people of all ages and skin types, and is caused by the destruction of melanocytes, the cells responsible for skin pigmentation. Treatment options for vitiligo include topical medications, phototherapy, and surgical procedures.
The vitiligo market within the context of dermatology is a growing field, with a range of products and services available to treat the condition. Topical medications, such as corticosteroids and calcineurin inhibitors, are commonly used to reduce the appearance of vitiligo. Phototherapy, such as narrowband UVB, is also used to stimulate the production of melanocytes. Surgical procedures, such as skin grafting and tattooing, are also available to treat vitiligo.
Companies in the vitiligo market include Galderma, Leo Pharma, and Sun Pharma. Other companies, such as Allergan, Mylan, and Teva, also offer products and services for the treatment of vitiligo. Show Less Read more